As of 2025-06-05, the Fair Value of Clarity Pharmaceuticals Ltd (CU6.AX) is -0.76 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.08 AUD, the upside of Clarity Pharmaceuticals Ltd is -136.43%.
With the market price of 2.08 AUD and our fair value calculation, Clarity Pharmaceuticals Ltd (CU6.AX) is not a good investment. Investing in CU6.AX stocks now will result in a potential loss of 136.43%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -10.22 | -23.75 | -24.60 | -42.32 | -25.23 | |
| YoY growth | -46.99% | -132.40% | -3.57% | -72.03% | -63.75% | |
| Market Cap (mil) | 668.41 |
| P/E | |
| Forward P/E |
| EPS | -0.15 |
| Avg earnings growth rate | -63.75% |
| TTM earnings | -48.70 |